C. Paul
Impact in
- Dermatology top 0.01%
- Dermatology and Skin Diseases
- Immunology top 0.1%
- Psoriasis: Treatment and Pathogenesis
Papers in
- Immunology 190
- Psoriasis: Treatment and Pathogenesis 158
- Mast cells and histamine 18
- Dermatology 122
- Dermatology and Skin Diseases 80
- Co-authors
- Kristian Reich (40 shared papers)Kim Papp (22 shared papers)D. Jullien (47 shared papers)F. Aubin (34 shared papers)P. Joly (42 shared papers)Michel Le Maître (31 shared papers)S. Aractingi (30 shared papers)Mark Lebwohl (29 shared papers)
- Journals
- Journal of the European Academy of Dermatology and Venereology (86 papers)British Journal of Dermatology (55 papers)Journal of the American Academy of Dermatology (25 papers)Dermatology (19 papers)Acta Dermato Venereologica (9 papers)
- Partner nations
- FranceUnited StatesGermany
In The Last Decade
C. Paul
379 papers receiving 16.2k citations
C. Paul's Hit Papers
Peers
Comparison fields: 5 of 160
- Dermatology 6.5k
- Immunology 8.1k
- Immunology and Allergy 1.8k
- Rheumatology 2.4k
- Pathology and Forensic Medicine 1.4k
Countries citing papers authored by C. Paul
This map shows the geographic impact of C. Paul's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Paul with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Paul more than expected).
Fields of papers citing papers by C. Paul
This network shows the impact of papers produced by C. Paul. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Paul. The network helps show where C. Paul may publish in the future.
Co-authors
The 25 scholars most cited alongside C. Paul, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 416 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Comparison of ixekizumab with etanercept or placebo in moderate-to-severe psoriasis (UNCOVER-2 and UNCOVER-3): results from two phase 3 randomised trials Hit paper breakdown → | 2015 | 664 |
| 2 | 2014 | 415 | |
| 3 | 2016 | 384 | |
| 4 | Efficacy and safety of apremilast, an oral phosphodiesterase 4 inhibitor, in patients with moderate‐to‐severe plaque psoriasis over 52 weeks: a phase III, randomized controlled trial (ESTEEM 2) Hit paper breakdown → | 2015 | 355 |
| 5 | Abrocitinib versus Placebo or Dupilumab for Atopic Dermatitis Hit paper breakdown → | 2021 | 306 |
| 6 | 2002 | 280 | |
| 7 | 2003 | 277 | |
| 8 | Bimekizumab versus Secukinumab in Plaque Psoriasis Hit paper breakdown → | 2021 | 248 |
| 9 | 2013 | 244 | |
| 10 | 2014 | 238 | |
| 11 | 1996 | 228 | |
| 12 | 2010 | 222 | |
| 13 | 2019 | 222 | |
| 14 | 2012 | 212 | |
| 15 | 2013 | 210 | |
| 16 | 2015 | 208 | |
| 17 | 2002 | 201 | |
| 18 | 2006 | 196 | |
| 19 | 2013 | 191 | |
| 20 | Deucravacitinib versus placebo and apremilast in moderate to severe plaque psoriasis: Efficacy and safety results from the 52-week, randomized, double-blinded, phase 3 Program fOr Evaluation of TYK2 inhibitor psoriasis second trial Hit paper breakdown → | 2022 | 190 |
About C. Paul
C. Paul is a scholar working on Immunology, Dermatology, Epidemiology, Rheumatology and Pathology and Forensic Medicine, having authored 416 papers that have together received 16.7k indexed citations. Recurring topics across this work include Psoriasis: Treatment and Pathogenesis (158 papers), Dermatology and Skin Diseases (80 papers), Autoimmune Bullous Skin Diseases (22 papers), Nail Diseases and Treatments (19 papers), Mast cells and histamine (18 papers), Spondyloarthritis Studies and Treatments (16 papers), Food Allergy and Anaphylaxis Research (16 papers) and Pharmaceutical studies and practices (15 papers). The work is most often cited by research in Dermatology (6.5k citations), Immunology (8.1k citations), Immunology and Allergy (1.8k citations), Rheumatology (2.4k citations) and Pathology and Forensic Medicine (1.4k citations). C. Paul has collaborated with scholars based in France, United States and Germany. Frequent co-authors include Kristian Reich, Kim Papp, D. Jullien, F. Aubin, P. Joly, Michel Le Maître, S. Aractingi, Mark Lebwohl, B. Cribier and L. Misery. Their work appears in journals such as Journal of the European Academy of Dermatology and Venereology, British Journal of Dermatology, Journal of the American Academy of Dermatology, Dermatology and Acta Dermato Venereologica.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.